covid-19vaccines
Scope
Date
~
-
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
ASK 2022
Korean real estate investors look to secure liquidity post-pandemic
South Korean real estate investors prefer liquidity and stable payback on investment, as well as investing in debts amid market uncertainty. The lim...
May 25, 2022 (Gmt+09:00)
-
Travel & Leisure
Lotte Hotel Yangon: Pain for POSCO International, Hotel Lotte
South Korea’s POSCO International Corp. and Hotel Lotte Co. have been suffering from sluggish earnings of their five-star hotel in Yangon, Mya...
May 23, 2022 (Gmt+09:00)
-
Real estate
Korea's top real estate managers bulk up assets in COVID-19
Real estate funds in South Korea have increased by 27% to 130 trillion won ($101.4 billion) from 102 trillion won over the past two years, accordi...
May 13, 2022 (Gmt+09:00)
-
Earnings
Korea’s major airlines continue to enjoy cargo boom
Korean Air Lines Co., the country’s top carrier, reported a record quarterly operating profit on the strong cargo business while its smaller d...
May 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
COVID test kit maker SD Biosensor buys Italian medical device firm
SD Biosensor Inc., South Korea’s top manufacturer of COVID-19 test kits, said on Friday that it has signed a deal to purchase a 100% stake i...
Apr 22, 2022 (Gmt+09:00)
-
Automobiles
SUV, minivan sales reach 52% of car market in Q1
Sales of leisure vehicles in South Korea, primarily sport utility vehicles (SUVs) and minivans, exceeded half of domestic finished car sales in the ...
Apr 18, 2022 (Gmt+09:00)
-
Private equity
MBK sees most productive year ever, returning $5.3 bn to investors
MBK Partners will be bold in moving into more Asian markets this year, wrote the company's founder and chairman Michael ByungJu Kim, in his annual l...
Mar 30, 2022 (Gmt+09:00)
-
Private equity
MBK sees most productive year ever, returning $5.3 bn to investors
MBK Partners will be bold in moving into more Asian markets this year, wrote the company's founder and chairman Michael ByungJu Kim, in his annual l...
Mar 27, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience becomes first to win domestic COVID-19 vaccine contract
SK Bioscience Co. said it reached a deal with Korea’s disease control agency to supply 10 million doses of the country’s first experimen...
Mar 22, 2022 (Gmt+09:00)
language -
Airlines
Global airlines raise flights to pre-COVID levels on border reopening
Global airlines are increasing flights to pre-pandemic levels as countries worldwide are opening up their borders to support the tourism sector, ram...
Mar 14, 2022 (Gmt+09:00)
language -
Korean stock market
Korea reopening stocks rally as govt. eases COVID-19 restrictions
South Korea’s reopening stocks jumped on Friday as the government eases COVID-19-curbing restrictions and as the number of the Omicron variant...
Mar 11, 2022 (Gmt+09:00)
-
Electronics
Samsung Smart Monitor M8 available in S.Korea
The new Samsung Smart Monitor M8 is now available for sale in South Korea, Samsung Electronics Co. announced on Sunday.The product can stream serv...
Mar 06, 2022 (Gmt+09:00)
-
Entertainment
K-pop shares rebound on return to offline concerts
Shares of major South Korean entertainment companies are on an upward trend this month. The rebound is thanks to eased COVID-19 restrictions leading...
Feb 24, 2022 (Gmt+09:00)
-
Earnings
SK Bioscience posts record earnings driven by COVID-19 vaccines
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, has posted record 2021 revenue and operating profit, boosted by contrac...
Feb 08, 2022 (Gmt+09:00)
-
Pharmaceuticals
Celltrion, Humasis to ship $300 mn COVID-19 test kits to US
South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...
Feb 04, 2022 (Gmt+09:00)
-
Korean chipmakers
Samsung cuts NAND output in Xian on COVID-19 lockdown
Samsung Electronics Co., the world’s largest NAND flash memory chipmaker, said on Wednesday it is adjusting operations at its manufacturing fa...
Dec 29, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...
Dec 24, 2021 (Gmt+09:00)
language -
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Economy
Korea lawmakers approve record $515 bn budget for 2022
South Korea’s parliament on Dec. 3 approved a record $515 billion spending for 2022 to support a recovery in Asia’s fourth-largest econo...
Dec 03, 2021 (Gmt+09:00)
-
COVID-19
Celltrion to export COVID-19 treatment to Europe in 2021
South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...
Nov 30, 2021 (Gmt+09:00)
language -
Supply chain
Korea Inc. braces for rising costs, supply chain risks, volatile FX
Hopes for improving corporate earnings are rising as countries around the world are relaxing their anti-COVID-19 measures, but South Korean companie...
Nov 22, 2021 (Gmt+09:00)
-
Pharmaceuticals
Samsung Biologics wins another Eli Lilly COVID treatment order
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...
Nov 19, 2021 (Gmt+09:00)
-
COVID-19
SK seeks to make Pfizer, Merck COVID-19 pills in CMO deals
SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...
Nov 17, 2021 (Gmt+09:00)
language -
COVID-19
Celltrion wins COVID-19 treatment approval from Europe
South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...
Nov 15, 2021 (Gmt+09:00)
language -
Business & Politics
Samsung heir Lee on US trip for foundry investment, COVID vaccines
Jay Y. Lee, vice chairman and de facto leader of South Korea’s top conglomerate Samsung, has embarked on a business trip to North America to f...
Nov 14, 2021 (Gmt+09:00)
-
BNP Paribas Asset Management
[ASK 2021] Infra Debt Key Market Trends in a Post-Covid Environment
Infra Debt Key Market Trends in a Post-Covid Environment Climate impact investing and digital infra Benefits of integrating ESG i...
Nov 04, 2021 (Gmt+09:00)
-
Energy
Korean refiners ramp up runs to pre-COVID-19 level
South Korean refiners ramped up runs of their crude distillation units (CDUs) to a level before the outbreak of the COVID-19, probably exceeding 80%...
Oct 06, 2021 (Gmt+09:00)
-
Entertainment
BTS heads to LA for first live concert since COVID-19
BTS will travel to Los Angeles in November for its first live concert since the outbreak of the COVID-19 pandemic. BTS said on Sept. 28 on its offic...
Sep 28, 2021 (Gmt+09:00)
language
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand